The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study | Zendy

Amedeo De Nicolò | Zendy; Andrea Calcagno | Zendy; Ilaria Motta | Zendy; Elisa De Vivo | Zendy; Antonio D’Avolio | Zendy; Giovanni Di Perri | Zendy; Lubbe Wiesner | Zendy; Ismaeel Ebrahim | Zendy; Gary Maartens | Zendy; Catherine Orrell | Zendy; Helen McIlleron | Zendy

Open Access

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study

Author(s) -

Amedeo De Nicolò,

Andrea Calcagno,

Ilaria Motta,

Elisa De Vivo,

Antonio D’Avolio,

Giovanni Di Perri,

Lubbe Wiesner,

Ismaeel Ebrahim,

Gary Maartens,

Catherine Orrell,

Helen McIlleron

Publication year - 2022

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00136-22

Subject(s) - darunavir , ritonavir , dolutegravir , medicine , peripheral blood mononuclear cell , pharmacokinetics , pharmacology , rifampicin , bioequivalence , tolerability , interquartile range , gastroenterology , adverse effect , viral load , chemistry , human immunodeficiency virus (hiv) , antiretroviral therapy , virology , tuberculosis , biochemistry , pathology , in vitro

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research